SCHEDULE: Janus Henderson Discloses Biohaven Stake

Janus Henderson Group plc has reported beneficial ownership of 11.7% of Biohaven Ltd. common shares, totaling 17,534,612 shares, as of March 31, 2026.

Summary

• Janus Henderson Group plc, through its various asset management subsidiaries, has filed a Schedule 13G indicating beneficial ownership of 17,534,612 common shares of Biohaven Ltd.
• This holding represents 11.7% of the total class of securities.
• The filing is an amendment (Amendment No. 2) to a previous filing, with the event date requiring this statement being March 31, 2026.
• The reporting entity, Janus Henderson Group plc, is a holding company for several SEC-registered investment advisers and their foreign equivalents.
• These asset managers exercise investment and/or voting discretion on behalf of various clients, including investment companies, other investment advisers, and institutional and retail separate accounts.
• While the asset managers may be deemed beneficial owners, they disclaim ownership of dividends and proceeds from the sale of these securities.
• None of the individual Managed Portfolios own more than five percent of Biohaven Ltd.'s common shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on existing ownership stakes rather than new developments or financial performance.

Positives

• Significant stake held by a major investment management group, potentially indicating confidence in Biohaven Ltd.'s prospects.
• The filing clarifies the beneficial ownership structure, providing transparency to investors.
• The holding of 11.7% suggests a substantial investment in Biohaven Ltd.

Negatives

• The filing does not contain financial performance data for Biohaven Ltd., only ownership information.
• The disclaimer of ownership for dividends and sale proceeds means Janus Henderson Group plc does not directly benefit from these actions, but rather their clients do.

Risks

• The filing does not explicitly mention any risks associated with Biohaven Ltd. itself, as it is a Schedule 13G filing focused on ownership.
• Potential for future changes in ownership by Janus Henderson Group plc or its subsidiaries, which could impact Biohaven Ltd.'s stock.

Future Outlook

This filing is primarily an ownership disclosure and does not contain forward-looking statements or guidance regarding Biohaven Ltd.'s future performance. The future outlook for Biohaven Ltd. would be found in its own financial reports.

Management Comments

• Janus Henderson Group plc, through its asset managers, may be deemed beneficial owners of 17,534,612 common shares of Biohaven LTD.
• The Asset Managers generally exercise investment and/or voting discretion on behalf of their clients which include investment companies, other investment advisers, institutional separate accounts and retail separate accounts.
• The Asset Managers do not have the right to receive any dividends from, or the proceeds from the sale of, the securities held in the Managed Portfolios and disclaim any ownership associated with such rights.

Industry Context

StockSavvy.ai notes that significant stakes held by large asset managers like Janus Henderson Group plc in publicly traded companies are common and often reflect active portfolio management strategies. Such filings provide transparency regarding institutional investor influence.

Stakeholder Impact

• Shareholders of Biohaven Ltd. are informed of a significant institutional investor's holdings, which can influence market perception.
• Investors in Janus Henderson Group plc's funds are indirectly affected by the performance of Biohaven Ltd. shares held within those funds.

Next Steps

• Janus Henderson Group plc will continue to hold its stake in Biohaven Ltd. unless its investment strategy changes.
• Future amendments to this Schedule 13G filing will be required if there are material changes in ownership.

Key Dates

Keywords

Biohaven Ltd., Janus Henderson Group plc, Schedule 13G, Beneficial Ownership, Common Shares, Investment Management, SEC Filing, Securities Exchange Act